OncoDecipher

 Many precision biomarker-driven therapies are being developed for treatment of various cancers.

However, there are many cancers for which biomarkers have not yet been identified.

Despite the numerous effective personalized treatments on the market today, only a limited number of patients qualify for care.

The discovery of cancer driver mutations has traditionally focused on mutations that directly change amino acids, the building blocks of protein-coding genes.

OncoDecipher identifies the “hidden mutations”  that result in a modified gene product.

Targeting these 'hidden biomarkers' with existing and novel treatments will expand the opportunity for patients otherwise, ineligible for care.